AICTE Approved | PCI Recognized | RGUHS Affiliated | Established 1983

Department of Pharmaceutics

InTake

15

Level of Study

Post Graduate Degree

Mode Of Program

Choice Based Credit System(CBCS)

Duration

2 years (4 Semester)

Overview

The Department of Pharmaceutics, established in 2008, is dedicated to the study and development of dosage forms and advanced drug delivery systems. The department aims to equip students with strong theoretical knowledge and practical skills to meet the needs of the pharmaceutical industry and academia.

With a team of highly qualified and experienced faculty members, the department provides guidance in both academic and research pursuits. It is supported by state-of-the-art laboratories and modern facilities that foster innovation and hands-on learning.

Our graduates are well-prepared to pursue higher education, including doctoral programs, or to take up rewarding careers in pharmaceutical industries, research organizations, and academic institutions.

Vision and Mission

Vision

To emerge as a leading centre of excellence in Pharmaceutics by advancing innovative research, fostering skilled pharmaceutical professionals, and contributing to the development of safe, effective, and high-quality drug delivery systems for the benefit of society.

Mission

  • To provide quality education through outcome-based teaching and hands-on practical training.
  • To promote advanced research and innovation in formulation development and drug delivery systems through state-of-the-art laboratories and collaborative research opportunities.
  • To develop competent professionals capable of contributing effectively to academia and the pharmaceutical industry.
  • To strengthen collaborations with pharmaceutical industries, research organisations, and academic institutions for enhanced research and professional development.

Definition and scope of Pharmaceutics

Pharmaceutics is the discipline of pharmaceutical sciences that deals with the design, formulation, preparation, and evaluation of safe and effective dosage forms to ensure the proper delivery of drugs to the body

Scope of Pharmaceutics

The scope of Pharmaceutics covers the design and development of safe and effective dosage forms, from pre-formulation studies to large-scale manufacturing. It includes understanding drug properties, selecting suitable excipients, and applying various processes such as mixing, granulation, drying and packaging. With advancing technology, pharmaceutics plays a major role in developing novel drug delivery systems that improve stability, bioavailability and patient convenience.

Curriculum & Courses Offered.

D PHARM:

  • Pharmaceutics ( I Year )
  • Pharmacy Law and Ethics ( II Year )
  • Hospital and Clinical Pharmacy ( II Year )

PHARM D:

  • Pharmaceutics ( I Year )
  • Pharmaceutical Jurisprudence ( III Year )
  • Pharmaceutical Formulations ( III Year )
  • Biopharmaceutics and Pharmacokinetics ( IV Year )

 

B PHARM:

  • Pharmaceutics  I ( Semester I )
  • Physical Pharmaceutics I ( Semester III )
  • Pharmaceutical Engineering ( Semester III )
  • Physical Pharmaceutics II ( Semester IV )
  • Industrial Pharmacy I ( Semester V )
  • Pharmaceutical Jurisprudence ( Semester V )
  • Biopharmaceutics and Pharmacokinetics ( Semester VI )
  • Industrial Pharmacy II ( Semester VII )
  • Novel Drug Delivery System ( Semester VII )
  • Practice School ( Semester VII )
  • Pharma Marketing Management ( Semester VIII )
  • Pharmaceutical Regulatory Science ( Semester VIII )
  • Project Work ( Semester VIII )

M PHARM :

  • Modified Release Drug  Delivery System ( Semester I )
  • Modern Pharmaceutics ( Semester I )
  • Pharmaceutical Regulatory Affair ( Semester I )
  • Molecular Pharmaceutics ( Semester II )
  • Advanced Biopharmaceutics and Pharmacokinetics( Semester II )
  • Computer Aided Drug Delivery System ( Semester II )
  • Cosmetic and Cosmeceuticals ( Semester II )
  • Dissertation (Semester III & IV )

Career opportunities in Pharmaceutics

Graduates specializing in Pharmaceutics have diverse career opportunities in the pharmaceutical industry, including formulation and development, production, quality control, regulatory affairs, and research and development. They can work in sectors such as dosage form design, drug delivery innovation, manufacturing, and pharmaceutical technology. Opportunities also extend to academics, contract research organizations (CROs), and pharmaceutical consultancy, providing a strong platform for professional growth in both industry and research environments. 

Sree Siddaganga College of Pharmacy organized campus recruitment drives by inviting various pharmaceutical companies, including Somerset Therapeutics Pvt. Ltd., Omega Health Care, HighSource HR Solutions Pvt. Ltd., Health Heal, and CorroHealth Infotech Pvt. Ltd. Students actively participated in the interviews, and several of them secured placements and joined their respective organizations.

Infrastructure & Facilities

The Department houses well-equipped laboratories to support both academic and research activities:

  • UG Lab 1: Pharmaceutics, Industrial Pharmacy I
  • UG Lab 2: Pharmaceutical Engineering
  • UG Lab 3: Physical Pharmaceutics I & II
  • PG Research Lab 1: Pharmaceutics Practicals I & II 
  • PG Research Lab 2: Dissertation work for final year students

 

Formulation Unit: The unit facilitates key operations such as powder blending using ball mills, granule drying, and tablet compression through both single-station and rotary tablet punching machines, followed by tablet coating processes. It also supports liquid formulation through controlled liquid-filling systems. Additionally, the unit enables the preparation of multiparticulate dosage forms, including pellets produced using an extruder and spheronizer. These activities provide students with practical exposure to industrial formulation techniques and strengthen their understanding of pharmaceutical manufacturing processes.

Ampoule clarity test apparatus

Autoclave

Ball mill

Capsule filling machine

Coating pan

Collapsible tube filling and sealing equipment

Collapsible tube sealing machine

Digital Friability test apparatus

Digital pH meter

Disintegration apparatus

Disintegration test apparatus

Dissolution Tester (8 station)

Dry Granulator

Friability test apparatus

Hot Air Ovens

Incubator

Lab Model Roll Compactor

Mini Melt Extruder &

Spheronizer

Mixing watt with stirrer

Orbital shaker

Pelletizer

Planetary Mixer

Roll compactor

Rotary Tablet Compression

Machine (10 station)

Single Punch Tablet Compression Machine

Stability Test Chambers

Station (Accessory)

Tablet dissolution test apparatus

Tablet hardness tester

Ultra Homogenizer

Ultra Sonicators

UV-Visible Spectrophotometer

Achievement and Recognition

Sl No Name of Participant Event Activity Topic Organized By
1 Manoj M Jadeda Manipal Pharmaceutical Conference (MPCON)-2025 Presented a Poster Design, optimization and characterization of Melatonin-loaded Solid Lipid Nanoparticles for enhanced treatment of sleep disorders. Manipal College of Pharmaceutical Sciences (MCOPS), MAHE, Manipal.
2 Nandeesh Umapati Jadimath Manipal Pharmaceutical Conference (MPCON)-2025 Presented a Poster Formulation and In-vitro evaluation Ufasomal topical gel containing antifungal agent. Manipal College of Pharmaceutical Sciences (MCOPS), MAHE, Manipal.
3 Rajesh T S Manipal Pharmaceutical Conference (MPCON)-2025 Presented a Poster Green synthesis, characterization and gel formulation of silver nanoparticles using wild YAM LEAF extract. Manipal College of Pharmaceutical Sciences (MCOPS), MAHE, Manipal.
4 Thanushree H N Pharma Anbeshan 2025 Presented a Poster Formulation and evaluation of glipizide mucoadhesive buccal films by using natural protein. Amity Institute of Pharmacy, Amity University, Bengaluru.

Industry Collaboration

A series of seminars on Pharmacovigilance was conducted on 30th August 2025 in collaboration with industry experts from TCS, IQVIA, and Acrol.

Research Activities

(I) On-going Research Projects- 02 [Grant amount: 5.925 Lakhs]

STUDENT GRANTS 

  • Mr. Harshith S, V Pharm D, has received 0.175 lakhs of grant amount under the guidance of Dr. Hemalatha KP for the project entitled “Preparation and evaluation of Liquorice raft forming tablets by using pellets prepared by extrusion spheronization” under the RGUHS UG Research Project for the year 2025–26, funded by the Advanced Research Wing, RGUHS, Bengaluru. Duration: Three months (Dec 2025 to Feb 2026). Project Code: UG25PHA0836.
  • Ms. Chandana Y, V Pharm D, has received 0.25 lakhs of grant amount under the guidance of Dr. Mancy S.P. for the project entitled “Formulation and Evaluation of Cissus quadrangularis herbal gummy bear” under the RGUHS UG Research Project for the year 2025–26, funded by the Advanced Research Wing, RGUHS, Bengaluru. Duration: Three months (Dec 2025 to Feb 2026). Project Code: UG25PHA0820.

 

FACULTY GRANTS 

  • Dr. Hemalatha KP, Manjunath K and Vijayakumar S has received grant amount of 5.50 Lakhs for the research project entitled “In Vitro, and In Vivo Studies of Functionalized Multiwalled Carbon Nanotubes with Vincristine Loaded Liposomes and Monoclonal Antibodies – A Targeted Approach for Enhanced Breast Cancer Treatment” under Faculty Grant for the year 2024-25 funded by Advanced Research Wing, RGUHS, Bangalore, Duration: Two years (April 2025 to April 2027). Project code: 24PHA329.

 

(II) Research Grant Completed- 06 [Total grant amount: 28.90 Lakhs]

STUDENT GRANTS 

  • Mr. Harshith S, III Pharm D, has received 0.13 lakhs of grant amount under the guidance of Dr. Hemalatha K. P. for the project entitled “Design, Optimization and Characterisation of Pomegranate Extract Based Raft Forming Tablets” under the RGUHS UG Research Project for the year 2024–25, funded by the Advanced Research Wing, RGUHS, Bengaluru. Duration: Three months (Feb 2025 to May 2025). Project Code: UG24PHA0818.

 

FACULTY GRANTS 

  • Dr. S. T. Bhagawati and Dr. K. Manjunath have received a grant amount of 2.00 Lakhs for the project entitled “Development of fast dissolving buccal films containing raloxifene nanocrystals to enhance its solubility and bioavailability” under the RGUHS Research Grant Scheme funded by RGUHS, Bengaluru. Duration: 2 years (Jan 2018 to Dec 2019). Project Code: 18P010.
  • Dr. P. Ashok Kumar and Dr. K. Manjunath have received a grant amount of 2.00 Lakhs for the project entitled “Preparation and Characterization of Novel Controlled Release Microspheres of Type-II Antidiabetic Drug Using In-situ Synthesized pH-Sensitive Acrylamide-Grafted Gums” under the RGUHS Research Grant Scheme funded by RGUHS, Bengaluru. Duration: 2 years (Jan 2017 to Dec 2018).
  • Dr. K. Manjunath and Dr. Suresh V. Kulkarni have received a grant amount of 4.50 Lakhs for the project entitled “Development and Bio-distribution of Solid Lipid Nanoparticles of an Anti-Alzheimer’s Drug – A Targeting Approach to Brain” under the RGUHS Research Grant Scheme funded by RGUHS, Bengaluru. Duration: 4.0 years (Jan 2016 to Dec 2019).
  • Dr. K. Manjunath and Dr. D. B. A. Narayana have received a grant amount of 20.00 Lakhs for the project entitled “Establishment of a Regional Facility for Developing Improved Stable Granules of Ayurvedic Churnas for Enhancing Patient Compliance” under the VGST Research Grant Scheme funded by the Vision Group on Science and Technology, Government of Karnataka. Duration: 3 years (Jan 2013 to Dec 2015).
  • Dr. K. Manjunath has received a seminar grant of 15,000 for the program titled “Nanotechnology for Superior Drug Delivery Systems” under the RGUHS Seminar Grant Scheme funded by RGUHS, Bengaluru (2011).
  • Dr. K. Manjunath has received a seminar grant of 10,000 for the program titled “Nanotechnology for Superior Drug Delivery Systems” funded by APTI (2011).
  • Dr. K. Manjunath has received a research grant of 15,000 for the project entitled “Neem Gum as a Cheap and Alternative Source to Synthetic Pharmaceutical Excipients” under the RGUHS Research Grant Scheme funded by RGUHS, Bengaluru. Duration: 1 Year (Dec 2011 to Nov 2012).

List of Publications [2024-25]

  1. Harshith S, Hemalatha KP*, Mancy SP, Chandana Y. Advancements in traditional medicine: preparation and characterization of pomegranate extract raft forming tablets. Journal of Neonatal Surgery. 2025; 14(32s): 1987–2001, ISSN 1659-5110, SCImago Journal Rank Q4, Scopus cite score: 0.4, https://www.jneonatalsurg.com/index.php/jns/article/view/7686/6695
  2. Hemalatha KP*, Aradya M, Vijaykumar S, Mancy S P, Mamatha BC, Singh SK, Gupta G. Preparation, optimization and evaluation of anti-inflammatory, analgesic and inflammatory bowel disease of indomethacin raft forming tablets. International Journal of Environmental Sciences. 2025; 11(5a): 1747–1765, ISSN 0976-4402, SCImago Journal Rank Q3, Scopus cite score: 1.4, https://theaspd.com/index.php/ijes/article/view/3115/2382
  3. Pooja K G, Manjunath K*. Formulation and evaluation of fast dissolving buccal film containing dabigatran etexilate. European Journal of Pharmaceutical and Medical Research. 2025; 12(2): 372–378, ISSN 2394-3211, [Impact factor: 7.065].
  4. Pallavi Chalawadi, Manjunath K*. Formulation and evaluation of fast dissolving oral films containing benidipine hydrochloride. World Journal of Pharmaceutical Research. 2025; 14(3): 929–939, ISSN 2277-7105, [Impact factor: 8.084].
  5. Neha S, Bhagawati S, Manjunath K*, Surve R, Sawant R. Phytochemical profiling of Wrightia tinctoria leaf and identification of marker compound rutin by RP-HPLC analysis for the treatment of psoriasis. RGUHS Journal of Pharmaceutical Sciences. 2025; 15(3): 39–46, ISSN 2455-2062.
  6. Reshma Sawant, Manjunath K*, Bhagawati S, Surve R, Shivathaya N. Biogenic zinc oxide nanoparticles as a sustainable strategy for diabetes management. Research Journal of Science and Technology. 2025; 17(4): 297–304, ISSN 0975-4393, [Impact factor: 6.2].
  7. Reshma Sawant, Manjunath K*, Bhagawati S, Surve R, Shivathaya N. Pharmacognostic standardization of Stevia rebaudiana and its HPLC quantification for stevioside as sweetening compound. RGUHS Journal of Pharmaceutical Sciences. 2025; 15(1): 37–45, ISSN 2455-2062.
  8. Ashok Kumar P*, Usha TS, Bhagyashree, Ganavi KS, Shaik Asraful Abdul Kalam. Utilization patterns of anticoagulant and antiplatelet drugs in cardiovascular patients at a tertiary care hospital. Journal of Pharmaceutical Research International. 2025; 37(5): 76–88, ISSN 2456-9119, [Impact factor: 1.6].
  9. Ashok Kumar P*, Chandana MA, Kavana KP, Yaseen Khan, Ankosh Jadhav. Evaluation of switch over to definitive therapy from empirical therapy in adult patients admitted with lower respiratory tract infections. Journal of Pharmaceutical Research International. 2025; 37(4): 134–146, ISSN 2456-9119, [Impact factor: 1.6].
  10. Mancy SP, Hemalatha KP*, Manjunath K, Singh S K, Gupta G, Vishwas S, Kumar S V. Improving the efficiency of drug by incorporating in polymerized lipid nanoparticle for rheumatoid arthritis. European Journal of Pharmaceutical and Medical Research. 2024; 11(10): 146–152, ISSN 2394-3211, [Impact factor: 7.065]. https://storage.googleapis.com/innctech/ejpmr/article_issue/1727681432.pdf
  11. Gupta G, Afzal M, Moglad E, Ali H, Singh TG, Kumbhar P, Disouza J, Almuajri SS, Kazmi I, Alzarea SI, Hemalatha KP*, Goh BH, Singh SK, Dua K. Non-coding RNAs as key regulators of Gasdermin-D mediated pyroptosis in cancer therapy. Pathology Research and Practice. 2024;261:1–11. ISSN 0344-0338, Scopus indexed. Cited in WoS. doi:10.1016/j.prp.2024.155490
  12. Manoj YR, Manjunath K*. Development and evaluation of floating sustained release bilayer tablets containing cyproheptadine hydrochloride. World Journal of Pharmacy and Pharmaceutical Sciences. 2024; 12(12): 997–1012, ISSN 2278-4357, [Impact factor: 6.3].
  13. Ashok Kumar P*, Ananya BS, Anitha A, Harshitha KA, Sahana MN, Kavya TS. Regulatory requirements of orphan medicines in India as per CDSCO in comparison with Bhutan. European Journal of Pharmaceutical and Medical Research. 2024; 11(12): 203–207, ISSN 2394-3211, [Impact factor: 7.065].
  14. Ashok Kumar P*, Gagana KN, Ganashree H, Kavana TS, Madhu Charan DM, Puneeth KM. Regulatory requirements for cardiovascular disease in India as per CDSCO in comparison with United States. European Journal of Pharmaceutical and Medical Research. 2024; 11(10): 511–515, ISSN 2394-3211, [Impact factor: 7.065].
  15. Ashok Kumar P*, Divyashree, Manasa Shetty, Renuka V, Sudeep Gowda K, Yashaswini. Regulatory requirements of over-the-counter (OTC) drugs in India as per CDSCO in comparison with United States of America. European Journal of Pharmaceutical and Medical Research. 2024; 11(10): 561–570, ISSN 2394-3211, [Impact factor: 7.065].
  16. Ashok Kumar P*, Ashritha, Bhoomika K, Meghna SR, Rathna NR, Trishmita Saha. Regulatory requirements for medical devices in India as per CDSCO comparison with Spain. European Journal of Pharmaceutical and Medical Research. 2024; 11(10): 488–497, ISSN 2394-3211, [Impact factor: 7.065].
  17. Ashok Kumar P*, Darshini, Hima Shree M, Karthik BK, Katika Rahul, Poorvika KV. Regulatory requirements on blood and blood products in India as per CDSCO comparison with Canada. European Journal of Pharmaceutical and Medical Research. 2024; 11(10): 516–521, ISSN 2394-3211, [Impact factor: 7.065].
  18. Ashok Kumar P*, Kavyashree BL, Thejaswini S, Madhushree KS, Rohini SB, Rohini MC. Current regulatory requirements and regulations for the submission of ANDA in India comparison with Germany. European Journal of Pharmaceutical and Medical Research. 2024; 11(10): 481–487, ISSN 2394-3211, [Impact factor: 7.065].
  19. Ashok Kumar P*, Darshan R, Mohammed Shabaz Ahmed MS, Toufeeq Chowdry, Parmeshwar Biradar, Khalandar M. Biological medical product allergic, gene, recombinant protein in India comparison with Europe. European Journal of Pharmaceutical and Medical Research. 2024; 11(10): 373–376, ISSN 2394-3211, [Impact factor: 7.065].
  20. Ashok Kumar P*, Afifa Misba, Ameena Banu, Chethan L, Nizam Pasha, Noor Neha. Regulatory requirements of biological medical products using cells and tissues in India under CDSCO in comparison with Ethiopia. European Journal of Pharmaceutical and Medical Research. 2024; 11(10): 261–267, ISSN 2394-3211, [Impact factor: 7.065].

Faculty

Dr. K Manjunath

Professor & HOD

Dr. Suresh V, Kulkarni

Professor & Principal 

Dr. S T Bhagawati

Associate Professor

Dr. K P Hemalatha

Assistant Professor

Ms. Chaya M

 Assistant Professor

Ms. Mancy S P

 Assistant Professor

Ms. Sulochana S A

Assistant Professor